Here, we show that prolonged exposure of BRAF-mutant melanoma cells to vemurafenib treatment leads to the emergence of drug-resistant melanoma subpopulations characterized by an increase in CD271 expression with induced Akt3 and Nox4 activity and the subsequent EMT process. Here, AKT3 is linked to melanoma.